Indegene Stock Rises on Kotak Upgrade, Growth Outlook

  Published 11 months ago

Indegene shares rise 1.4% as Kotak raises fair value to 700 rupees, citing FY26 growth recovery and strong pipeline.

  • Stock hits 3.5% intraday high; Kotak maintains 'buy' rating amid stable demand despite tariff risks.
  • Double-digit FY26 revenue growth expected from digital biopharma services, led by North America revenue.
  • Average analyst rating 'hold' with 610 rupee median target; stock down 2% year-to-date.

You might like these

Honda Q4 Earnings: Sales Up, Profits Down

Wheels India Jumps on Strong Q1 Show

P&G CFO Resignation and New Leadership Announcement

U.S. Inflation Rises Amid Tariffs, Fed Cautious

India Eyes Rare Earth Magnet Push

Bharat Forge Sets Up Aerospace Ring Mill

Sun & Incyte Settle LEQSELVI Dispute

News that matters the most ⚡